MediPharm Labs Corp.
MEDIF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -3% | 9.3% | -10.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 22.4% | 28.2% | 38.7% | 30% |
| EBITDA | -$0 | -$0 | $0 | -$0 |
| % Margin | -14.9% | -28.3% | 0.5% | -9.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -18.7% | -31.9% | -3.6% | -14.3% |
| EPS Diluted | -0.01 | -0.009 | -0.001 | -0.004 |
| % Growth | -9.9% | -911.1% | 78.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |